Enhanced circulation effector composition and method
First Claim
Patent Images
1. A liposome composition, comprising liposomes, each having an outer layer of a hydrophilic, and an effector molecule attached to the distal ends of said chains, said effector molecule having binding affinity to a cell receptor, wherein said liposome-bound effector molecule binds to the cell receptor and sterically hinders the cell receptor.
1 Assignment
0 Petitions
Accused Products
Abstract
A liposome composition comprising small, surface-bound effector molecules is disclosed. The liposomes have a surface layer of hydrophilic polymer chains, for enhanced circulation time in the bloodstream. The effector molecules are attached to the distal ends of the polymer chains. In one embodiment, the effector is polymyxin B, for treatment of septic shock.
18 Citations
12 Claims
-
1. A liposome composition, comprising
liposomes, each having an outer layer of a hydrophilic, and an effector molecule attached to the distal ends of said chains, said effector molecule having binding affinity to a cell receptor, wherein said liposome-bound effector molecule binds to the cell receptor and sterically hinders the cell receptor.
-
7. A liposome composition for use in treating a condition mediated by binding of one binding member to a second binding member, comprising
liposomes, each having an outer layer of a hydrophilic polymer, an effector molecule attached to the distal ends of said chains, said effector molecule having binding affinity to a cell receptor, wherein said liposome-bound effector molecule binds to the cell receptor and sterically hinders the cell receptor.
Specification